Pharmacology Research Today is a free monthly online journal that collates and summarizes the latest research about Pharmacology, including details on pharmacogenomics, drug development, new medications.

Volume 7 (2011), Issue 7 (July)

1. Bridging the efficacy-effectiveness gap: a regulator's perspective on addressing variability of drug response.
   Nat Rev Drug Discov, 10(7): 495-506. [Abstract] [Full-text]
2. Untapped ethical resources for neurodegeneration research.
   BMC Med Ethics, 12: 9. [Abstract] [Full-text]
3. The initial pharmaceutical development of an artesunate/amodiaquine oral formulation for the treatment of malaria: a public-private partnership.
   Malar J, 10: 142. [Abstract] [Full-text]
4. Towards ambient temperature-stable vaccines: the identification of thermally stabilizing liquid formulations for measles virus using an innovative high-throughput infectivity assay.
   Vaccine, 29(31): 5031-9. [Abstract] [Full-text]
5. The prevalence and experience of Australian naturopaths and Western herbalists working within community pharmacies.
   BMC Complement Altern Med, 11: 41. [Abstract] [Full-text]
6. Strategies for improved stability of Peste des Petits Ruminants Vaccine.
   Vaccine, 29(31): 4983-91. [Abstract] [Full-text]
7. Discovering the targets of drugs via computational systems biology.
   J Biol Chem, 286(27): 23653-8. [Abstract] [Full-text]
8. Therapeutic agents and herbs in topical application for acne treatment.
   Int J Cosmet Sci, 33(4): 289-97. [Abstract] [Full-text]
9. Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study.
   Environ Mol Mutagen, 52(6): 425-39. [Abstract] [Full-text]
10. An in silico approach for the discovery of CDK5/p25 interaction inhibitors.
    Biotechnol J, 6(7): 871-81. [Abstract] [Full-text]
11. First BRET-based screening assay performed in budding yeast leads to the discovery of CDK5/p25 interaction inhibitors.
    Biotechnol J, 6(7): 860-70. [Abstract] [Full-text]
12. Engineering antibiotic production and overcoming bacterial resistance.
    Biotechnol J, 6(7): 812-25. [Abstract] [Full-text]
13. Will biofilm disassembly agents make it to market?
    Trends Microbiol, 19(7): 304-6. [Abstract] [Full-text]
14. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Pharmacol Res, 64(3): 169-75. [Abstract] [Full-text]
15. Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation.
    Nature, 475(7354): 96-100. [Abstract] [Full-text]
16. Biophysical mapping of the adenosine A2A receptor.
    J Med Chem, 54(13): 4312-23. [Abstract] [Full-text]
17. Application of chemical toxicity distributions to ecotoxicology data requirements under REACH.
    Environ Toxicol Chem, 30(8): 1943-54. [Abstract] [Full-text]
18. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    Circ Res, 109(2): 205-16. [Abstract] [Full-text]
19. A model for considering different discourse communities within the toxicological and environmental sciences: an approach for addressing jargon and personally subjective vocabulary.
    Toxicol Appl Pharmacol, 254(2): 215-20. [Abstract] [Full-text]
20. Advances in exposure and toxicity assessment of particulate matter: an overview of presentations at the 2009 Toxicology and Risk Assessment Conference.
    Toxicol Appl Pharmacol, 254(2): 141-4. [Abstract] [Full-text]
21. Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians.
    BMC Med Genet, 12: 80. [Abstract] [Full-text]
22. Disposable pipette extraction for gas chromatographic determination of codeine, morphine, and 6-monoacetylmorphine in vitreous humor.
    J Sep Sci, 34(14): 1716-21. [Abstract] [Full-text]
23. The trouble with translational medicine.
    J Intern Med, 270(2): 123-7. [Abstract] [Full-text]
24. Identification of cavities on protein surface using multiple computational approaches for drug binding site prediction.
    Bioinformatics, 27(15): 2083-8. [Abstract] [Full-text]
25. A comparison of lipase and trypsin encapsulated in mesoporous materials with varying pore sizes and pH conditions.
    Colloids Surf B Biointerfaces, 87(2): 464-71. [Abstract] [Full-text]
26. Spectroscopic approach of the interaction study of amphiphilic drugs with the serum albumins.
    Colloids Surf B Biointerfaces, 87(2): 447-53. [Abstract] [Full-text]
27. Investigating the effect of an arterial hypertension drug on the structural properties of plasma protein.
    Colloids Surf B Biointerfaces, 87(2): 489-97. [Abstract] [Full-text]
28. Voltammetric determination of cefpirome at multiwalled carbon nanotube modified glassy carbon sensor based electrode in bulk form and pharmaceutical formulation.
    Colloids Surf B Biointerfaces, 87(2): 423-6. [Abstract] [Full-text]
29. Protein adsorption behaviors onto photocatalytic Ti(IV)-doped calcium hydroxyapatite particles.
    Colloids Surf B Biointerfaces, 87(2): 472-9. [Abstract] [Full-text]
30. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
    Colloids Surf B Biointerfaces, 87(2): 454-63. [Abstract] [Full-text]
31. Dissipative crystallization of aqueous mixtures of potassium salts of poly(riboadenylic acid) and poly(ribouridylic acid).
    Colloids Surf B Biointerfaces, 87(2): 439-46. [Abstract] [Full-text]
32. Development of PEG-PLA/PLGA microparticles for pulmonary drug delivery prepared by a novel emulsification technique assisted with amphiphilic block copolymers.
    Colloids Surf B Biointerfaces, 87(2): 433-8. [Abstract] [Full-text]
33. In situ gelling hexagonal phases for sustained release of an anti-addiction drug.
    Colloids Surf B Biointerfaces, 87(2): 391-8. [Abstract] [Full-text]
34. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Colloids Surf B Biointerfaces, 87(2): 280-8. [Abstract] [Full-text]
35. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
    Colloids Surf B Biointerfaces, 87(2): 333-9. [Abstract] [Full-text]
36. Modulation of aggregation behavior of amphiphilic drug AMT under the influence of polymer molecular weight and composition.
    Colloids Surf B Biointerfaces, 87(2): 340-5. [Abstract] [Full-text]
37. Effects of chemical and physical parameters in the generation of microspheres by hydrodynamic flow focusing.
    Colloids Surf B Biointerfaces, 87(2): 361-8. [Abstract] [Full-text]
38. Discovery of selective bioactive small molecules by targeting an RNA dynamic ensemble.
    Nat Chem Biol, 7(8): 553-9. [Abstract] [Full-text]
39. A screen for regulators of survival of motor neuron protein levels.
    Nat Chem Biol, 7(8): 544-52. [Abstract] [Full-text]
40. A pharmacogenomic method for individualized prediction of drug sensitivity.
    Mol Syst Biol, 7: 513. [Abstract] [Full-text]
41. A yeast-based assay identifies drugs active against human mitochondrial disorders.
    Proc Natl Acad Sci U S A, 108(29): 11989-94. [Abstract] [Full-text]
42. The Danish National Prescription Registry.
    Scand J Public Health, 39(7): 38-41. [Abstract] [Full-text]
43. Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7.
    Int J Cancer, 129(2): 397-406. [Abstract] [Full-text]
44. Molecular modeling study of checkpoint kinase 1 inhibitors by multiple docking strategies and prime/MM-GBSA calculation.
    J Comput Chem, 32(13): 2800-9. [Abstract] [Full-text]
45. Ab initio prediction of protein-ligand binding structures by replica-exchange umbrella sampling simulations.
    J Comput Chem, 32(13): 2810-21. [Abstract] [Full-text]
46. A hypertension gene: are we there yet?
    Twin Res Hum Genet, 14(4): 295-304. [Abstract] [Full-text]
47. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.
    J Cell Physiol, 226(10): 2469-77. [Abstract] [Full-text]
48. Evaluation and identification of reliable reference genes for pharmacogenomics, toxicogenomics, and small RNA expression analysis.
    J Cell Physiol, 226(10): 2469-77. [Abstract] [Full-text]

© 2005-2013 Pharmacology Research Today. All Rights Reserved.